Sales 2024 * | 688M 54.17B | Sales 2025 * | 847M 66.64B | Capitalization | 3.51B 276B |
---|---|---|---|---|---|
Net income 2024 * | -107M -8.42B | Net income 2025 * | -1M -78.68M | EV / Sales 2024 * | 4.82 x |
Net cash position 2024 * | 199M 15.62B | Net cash position 2025 * | 306M 24.05B | EV / Sales 2025 * | 3.79 x |
P/E ratio 2024 * |
-31.1
x | P/E ratio 2025 * |
421
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.37% |
Latest transcript on HUTCHISON CHINA MED.
Managers | Title | Age | Since |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 31/12/04 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 30/06/08 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graeme Jack
BRD | Director/Board Member | 73 | 28/02/17 |
Dan Eldar
CHM | Chairman | 70 | 31/07/16 |
Edith Shih
BRD | Director/Board Member | 71 | 31/12/99 |
1st Jan change | Capi. | |
---|---|---|
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |